vs
Side-by-side financial comparison of ASHFORD HOSPITALITY TRUST INC (AHT) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
ASHFORD HOSPITALITY TRUST INC is the larger business by last-quarter revenue ($259.0M vs $196.0M, roughly 1.3× Axsome Therapeutics, Inc.). Axsome Therapeutics, Inc. runs the higher net margin — -14.6% vs -26.8%, a 12.2% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -6.0%). Axsome Therapeutics, Inc. produced more free cash flow last quarter ($-18.7M vs $-86.8M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -7.7%).
Ashford Hospitality Trust Inc is a U.S.-headquartered real estate investment trust focused on upper-upscale full-service hotel properties across key U.S. urban, suburban and resort markets. Its portfolio holds assets under top global hospitality brands, serving business and leisure travelers, with a focus on long-term value growth and stable shareholder returns.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
AHT vs AXSM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $259.0M | $196.0M |
| Net Profit | $-69.3M | $-28.6M |
| Gross Margin | — | — |
| Operating Margin | -2.6% | -13.8% |
| Net Margin | -26.8% | -14.6% |
| Revenue YoY | -6.0% | 65.0% |
| Net Profit YoY | 44.2% | 61.9% |
| EPS (diluted) | $-12.85 | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $259.0M | $196.0M | ||
| Q3 25 | $266.1M | $171.0M | ||
| Q2 25 | $302.0M | $150.0M | ||
| Q1 25 | $277.4M | $121.5M | ||
| Q4 24 | $275.5M | $118.8M | ||
| Q3 24 | $276.6M | $104.8M | ||
| Q2 24 | $316.5M | $87.2M | ||
| Q1 24 | $303.9M | $75.0M |
| Q4 25 | $-69.3M | $-28.6M | ||
| Q3 25 | $-60.1M | $-47.2M | ||
| Q2 25 | $-30.4M | $-48.0M | ||
| Q1 25 | $-20.0M | $-59.4M | ||
| Q4 24 | $-124.2M | $-74.9M | ||
| Q3 24 | $-57.9M | $-64.6M | ||
| Q2 24 | $50.3M | $-79.3M | ||
| Q1 24 | $71.6M | $-68.4M |
| Q4 25 | -2.6% | -13.8% | ||
| Q3 25 | 4.6% | -27.0% | ||
| Q2 25 | 16.3% | -24.5% | ||
| Q1 25 | 22.2% | -46.9% | ||
| Q4 24 | -17.8% | -61.1% | ||
| Q3 24 | 7.3% | -59.8% | ||
| Q2 24 | 42.8% | -89.5% | ||
| Q1 24 | 50.2% | -89.7% |
| Q4 25 | -26.8% | -14.6% | ||
| Q3 25 | -22.6% | -27.6% | ||
| Q2 25 | -10.1% | -32.0% | ||
| Q1 25 | -7.2% | -48.9% | ||
| Q4 24 | -45.1% | -63.1% | ||
| Q3 24 | -20.9% | -61.7% | ||
| Q2 24 | 15.9% | -91.0% | ||
| Q1 24 | 23.5% | -91.1% |
| Q4 25 | $-12.85 | $-0.55 | ||
| Q3 25 | $-11.35 | $-0.94 | ||
| Q2 25 | $-6.88 | $-0.97 | ||
| Q1 25 | $-4.91 | $-1.22 | ||
| Q4 24 | $-13.64 | $-1.54 | ||
| Q3 24 | $-12.39 | $-1.34 | ||
| Q2 24 | $2.50 | $-1.67 | ||
| Q1 24 | $5.99 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.1M | $322.9M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $-626.4M | $88.3M |
| Total Assets | $2.8B | $689.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.1M | $322.9M | ||
| Q3 25 | $81.9M | $325.3M | ||
| Q2 25 | $100.0M | $303.0M | ||
| Q1 25 | $85.8M | $300.9M | ||
| Q4 24 | $112.9M | $315.4M | ||
| Q3 24 | $119.7M | $327.3M | ||
| Q2 24 | $121.8M | $315.7M | ||
| Q1 24 | $111.1M | $331.4M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.8B | — | ||
| Q1 24 | $2.9B | — |
| Q4 25 | $-626.4M | $88.3M | ||
| Q3 25 | $-548.7M | $73.7M | ||
| Q2 25 | $-485.5M | $73.1M | ||
| Q1 25 | $-446.1M | $53.2M | ||
| Q4 24 | $-419.2M | $57.0M | ||
| Q3 24 | $-288.4M | $92.9M | ||
| Q2 24 | $-225.9M | $102.9M | ||
| Q1 24 | $-276.8M | $144.0M |
| Q4 25 | $2.8B | $689.8M | ||
| Q3 25 | $3.0B | $669.3M | ||
| Q2 25 | $3.1B | $639.8M | ||
| Q1 25 | $3.1B | $596.7M | ||
| Q4 24 | $3.2B | $568.5M | ||
| Q3 24 | $3.3B | $561.5M | ||
| Q2 24 | $3.3B | $548.2M | ||
| Q1 24 | $3.5B | $545.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $-18.7M |
| Free Cash FlowOCF − Capex | $-86.8M | $-18.7M |
| FCF MarginFCF / Revenue | -33.5% | -9.6% |
| Capex IntensityCapex / Revenue | 27.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-135.5M | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.7M | $-18.7M | ||
| Q3 25 | $5.5M | $1.0M | ||
| Q2 25 | $16.3M | $-32.4M | ||
| Q1 25 | $-25.0M | $-43.4M | ||
| Q4 24 | $-23.6M | $-26.2M | ||
| Q3 24 | $795.0K | $-18.6M | ||
| Q2 24 | $8.0M | $-30.1M | ||
| Q1 24 | $-46.5M | $-53.5M |
| Q4 25 | $-86.8M | $-18.7M | ||
| Q3 25 | $-226.0K | $988.0K | ||
| Q2 25 | $-3.6M | $-32.4M | ||
| Q1 25 | $-44.8M | $-43.7M | ||
| Q4 24 | $-131.6M | $-26.2M | ||
| Q3 24 | $-21.8M | $-18.7M | ||
| Q2 24 | $-22.9M | $-30.2M | ||
| Q1 24 | $-80.4M | $-53.6M |
| Q4 25 | -33.5% | -9.6% | ||
| Q3 25 | -0.1% | 0.6% | ||
| Q2 25 | -1.2% | -21.6% | ||
| Q1 25 | -16.2% | -36.0% | ||
| Q4 24 | -47.8% | -22.1% | ||
| Q3 24 | -7.9% | -17.9% | ||
| Q2 24 | -7.2% | -34.6% | ||
| Q1 24 | -26.5% | -71.4% |
| Q4 25 | 27.5% | 0.0% | ||
| Q3 25 | 2.1% | 0.0% | ||
| Q2 25 | 6.6% | 0.0% | ||
| Q1 25 | 7.2% | 0.3% | ||
| Q4 24 | 39.2% | 0.0% | ||
| Q3 24 | 8.2% | 0.1% | ||
| Q2 24 | 9.8% | 0.1% | ||
| Q1 24 | 11.2% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.16× | — | ||
| Q1 24 | -0.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHT
| Occupancy | $190.2M | 73% |
| Food And Beverage | $51.8M | 20% |
| Hotel Other | $16.6M | 6% |
AXSM
Segment breakdown not available.
